Diphenhydramine Hydrochloride 25mg Tablet
NDC Package 70692-148-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Diphenhydramine Hydrochloride 25mg tablets is temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:runny nosesneezingitchy, watery eyesitching of the nose or throattemporarily relieves these symptoms due to the common cold:runny nosesneezing. This formulation utilizes a tablet delivery system. Marketed by Strive Pharmaceuticals Inc, this product is identified by NDC 70692-148 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
70692-148-01
Package Description
100 TABLET in 1 PACKAGE
Product Code
70692-148
11-Digit Billing Format
70692014801
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Diphenhydramine Hydrochloride 25mg
Non-Proprietary Name
Diphenhydramine Hydrochloride 25mg
Substance Name
Diphenhydramine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1
Pharmacologic Class
Usage Information
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:runny nosesneezingitchy, watery eyesitching of the nose or throattemporarily relieves these symptoms due to the common cold:runny nosesneezing

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-20-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70692-148). Click a package code to view its specific billing and regulatory data.

70692-148-11
1000 TABLET in 1 BOTTLE
70692-148-40
400 TABLET in 1 BOTTLE
70692-148-46
1 BOTTLE in 1 CARTON / 72 TABLET in 1 BOTTLE
70692-148-62
600 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-148-01 identifies a specific commercial package of 100 tablet in 1 package of Diphenhydramine Hydrochloride 25mg, a human over the counter drug labeled by Strive Pharmaceuticals Inc. This tablet is formulated for oral use and contains diphenhydramine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc on December 20, 2018. The current certification is valid through December 31, 2026.

How is this Strive Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692014801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-148-01
11-Digit CMS (5-4-2)
70692-0148-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.